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Key Messages
1. The inhibition of SARS 
coronavirus (SCV) helicase by 
bismuth compounds is mediated 
via the abilities of bismuth ions 
to displace (essentially required) 
zinc ions that are bound to 
cysteine residues located within 
the metal-binding domain.
2. Several novel bismuth 
compounds targeting SCV 
helicase have been synthesised. 
These compounds can inhibit 
SCV helicase activity and viral 
growth and potentially target 
other viruses.
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Introduction
Severe acute respiratory syndrome (SARS) was first recognised in late 2002 and 
was shown to be caused by the SARS coronavirus (SCV).1,2 We have reported the 
purification and characterisation of the SCV helicase,3 and identified a number 
of lead compounds able to inhibit SCV helicase activities and viral growth.4,5 
One of these contained bismuth—ranitidine bismuth citrate (RBC). To reveal 
the mechanisms underlying RBC action, we investigated the interaction between 
zinc, bismuth, and the helicase protein. Mutational analysis was used to pinpoint 
the key amino acid residues necessary for the helicase function. Several novel 
bismuth compounds with SCV inhibiting activity were synthesised. This study 
was conducted from February 2005 to January 2007.
Characterisation of the Zn2+- SARS coronavirus helicase 
interaction
The N-terminal of the SCV helicase consisted of a cysteine rich domain: 
the metal-binding domain (MBD). Sequence alignment suggested that this 
entailed Zn2+ binding. To determine how helicase binds to Zn2+ ions, we used 
4-(2-pyridylazo) resorcinol / p-hydroxymercuriphenylsulfonic acid assay to 
demonstrate that zinc did indeed bind to the MBD of SCV helicase via the 
cysteine residues (Fig 1). 
 To study the effect on the structure of MBD upon zinc binding, we measured 
the circular dichroism of MBD (Fig 2). The zinc-bound form of MBD showed 
the characteristics expected of high helix content. However, addition of excess 
ethylenediaminetetraacetic acid to remove the zinc ions led to a decrease in 
ultraviolet light absorption, suggesting that the protein changed to a random 
structure in the absence of Zn2+. 
Mutational analysis of the SARS coronavirus helicase metal-
binding domain
To define the precise role of individual amino acids within the SCV helicase 
MBD, we individually mutated several key cysteine residues within the MBD. 
The mutant proteins were then studied by measuring their ATPase and unwinding 
activities. All the mutant proteins lost their activities.
Determination of the mechanism of ranitidine bismuth citrate–
mediated inhibition of SARS coronavirus helicase activity
Bi3+ is known to have a high affinity for thiolate sulphur.6 We therefore measured 
the ultraviolet light absorbance spectrum of the SCV helicase, both in the absence 
and presence of RBC. The cysteine-rich MBD was the target of the bismuth ion. 
Addition of Bi3+ to the Zn2+-bound form of MBD led to an increase in ultraviolet 
light absorbance, indicative of replacement of Zn2+ by Bi3+.7
Synthesis of bismuth complexes against SARS coronavirus
Bismuth compounds effectively inhibited SCV growth in cell culture. The 
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mechanism was through replacement of zinc bound to 
the MBD. We then designed and synthesised a series of 
bismuth complexes, including complexes of: bismuth 
porphyrin, bismuth macrocyclin, bismuth 12-crown-4, 
bismuth bipyridine, bismuth phenanthroline, bismuth 
nitrilotriacetate, bismuth ethylenediaminetetraacetic acid, 
and bismuth acetohydroxamate.3 The newly synthesised 
compounds were tested for their activity against SARS 
helicase. The two bismuth porphyrin complexes and RBC 
exhibited the the most significant inhibition activities as 
revealed by in vitro experiments.8
Conclusion
We determined the interaction between zinc, bismuth, and 
the helicase protein, enabling us to construct mechanistic 
models for bismuth-mediated inhibition of the SCV helicase 
functions. The zinc ions bound to the MBD of SCV helicase 
were replaced by bismuth ions upon addition of RBC and 
other bismuth compounds, resulting in dysfunction of the 
helicase. These compounds may also be used to inhibit 
other viruses.
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